Several financial giants are reportedly filing for crypto-related exchange-traded funds (ETFs) as they anticipate the ...

Bitcoin ( BTC 1.30%) had a phenomenal year in 2024. The cryptocurrency returned 119%, easily outperforming the 23% gain in ...

Carnegie Investment Counsel reduced its position in shares of VanEck Fallen Angel High Yield Bond ETF (NASDAQ:ANGL – Free Report) by 37.5% during the 4th quarter, according to its most recent 13F ...

Brookstone Capital Management raised its stake in VanEck Agribusiness ETF (NYSEARCA:MOO – Free Report) by 14.6% during the ...

Solana’s SOL token rocketed after a memecoin linked to President-elect Donald Trump launched on the popular blockchain ...

Cryptocurrency ETFs attracted industry attention this week as participants await the influences of Donald Trump’s ...

Bierman, chief market technician at Theo Trade and an adjunct professor of finance at Loyola University Chicago, says investors will be dealing with greater stock-market volatility and uncertainty ...

ProShares seeks SEC approval for leveraged, inverse, and futures XRP ETFs, ahead of Chair Gensler's departure.

As Gary Gensler’s final day as SEC Chair approaches on Jan. 20, the crypto industry has submitted a surge of ETF filings.

VanEck has submitted a filing with the U.S. Securities and Exchange Commission (SEC) for the launch of a new exchange-traded ...

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund launched on 12/20/2011.

VanEck seeks SEC approval for its "On-chain Economy" ETF, investing in crypto-related firms and products without direct crypto exposure.